Schobel Alexander Mark
SEC insider (Form 3/4/5 filer). CIK 0001406836. Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 9, 2024. Located in WARREN, NJ.
Companies Schobel Alexander Mark has filed insider reports for
- Aquestive Therapeutics, Inc. (AQST): Officer, Chief Innovation/Tech Officer
Schobel Alexander Mark
CIK: 0001406836
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Officer